MedTrace Logo

Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

NCT00905684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5446

Last updated 2012-03-07

No results posted yet for this study

Summary

This study is a prospective, company-sponsored, non-interventional cohort study of up to 5000 patients in European countries and countries in Middle East who are newly prescribed any available OC. Patients will be followed up approximately 6 months after initial visit. Selection of Study Population: Women can be enrolled after decision for treatment with Yasmin or any other OC has been made. Physicians should consult the full prescribing information for the respective OC before enrolling patients and familiarize themselves with the safety information in the product package label.

Conditions

  • Contraception

Interventions

DRUG

EE30/DRSP (Yasmin, BAY86-5131)

Patients under regular daily life treatment receiving Yasmin according to local drug information

DRUG

Any other OC

Patients under regular daily life treatment receiving any other OC according to local drug information

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Completion
2011-12-31

Countries

  • Albania
  • Bahrain
  • Egypt
  • Hungary
  • Jordan
  • Kenya
  • Kuwait
  • Lebanon
  • North Macedonia
  • Oman
  • Qatar
  • Saudi Arabia
  • United Arab Emirates

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00905684 on ClinicalTrials.gov